Company Valuation: Bio-Rad Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,439 12,460 9,399 9,182 8,212 7,817 - -
Change - -44.47% -24.57% -2.31% -10.57% -4.81% - -
Enterprise Value (EV) 1 22,439 11,868 8,992 8,730 7,874 7,068 6,851 6,710
Change - -47.11% -24.24% -2.91% -9.8% -10.24% -3.06% -2.06%
P/E Ratio 5.38x - -14.8x -5.03x 10.9x 34.8x 34.1x 34.3x
PBR - 1.27x 1.05x 1.41x 1.11x 1.12x 1.08x -
PEG - - - -0x -0x -0.5x 14.93x -48.65x
Capitalization / Revenue 7.68x 4.45x 3.52x 3.58x 3.18x 3.04x 2.97x 2.92x
EV / Revenue 7.68x 4.24x 3.37x 3.4x 3.05x 2.75x 2.6x 2.51x
EV / EBITDA 33.1x 17.8x 16.8x 18.2x 17.4x 17.7x 16.1x 15.2x
EV / EBIT 39.3x 22.7x 23.7x 26.4x 25.3x 26.5x 23x 20.8x
EV / FCF 41.9x 127x 24x - - 22.7x 21.8x 20.6x
FCF Yield 2.39% 0.79% 4.17% - - 4.41% 4.58% 4.86%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 140.6 - -21.82 -65.36 27.85 8.32 8.51 8.45
Distribution rate - - - - - - - -
Net sales 1 2,923 2,802 2,671 2,566 2,583 2,567 2,635 2,676
EBITDA 1 677.5 667.9 535.9 479.5 453.2 398.6 426.3 442.3
EBIT 1 571.2 524 378.9 331.3 311.6 266.8 298 322
Net income 1 4,246 -3,628 -637.3 -1,844 759.9 224.8 229.7 228.3
Net Debt 1 - -592.5 -407.6 -452.1 -337.7 -749 -965.4 -1,107
Reference price 2 755.57 420.49 322.89 328.51 302.99 289.95 289.95 289.95
Nbr of stocks (in thousands) 29,918 29,824 29,145 27,997 26,975 26,762 - -
Announcement Date 2/10/22 2/16/23 2/15/24 2/13/25 2/12/26 - - -
1USD in Million2USD
Estimates

P/E Ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
34.77x2.75x17.73x-.--% 7.82B
22.3x3.3x12.41x2.87% 154B
20.2x3.49x12.54x3.56% 103B
33.69x8.2x21.49x1.19% 55.68B
14.83x0.18x11.12x0.84% 54.76B
36.26x2.92x10.02x2.65% 40.1B
35.74x1.32x11.63x0.22% 31.57B
30.32x5.41x17.24x-.--% 28.64B
39.36x6.81x24.56x0.27% 23.41B
24.13x3.08x12.56x1.34% 20.6B
Average 29.16x 3.75x 15.13x 1.29% 52.02B
Weighted average by Cap. 25.68x 3.64x 13.94x 2.06%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. BIO Stock
  4. Valuation Bio-Rad Laboratories, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!